Sbir phase i topic 402: artificial intelligence-aided imaging for cancer prevention, diagnosis, and monitoring
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91020C00051
- Awardee
-
Reveal Biosciences Inc. UEI HEEAZ9FXXM13
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $392,343
Award facts
- Opportunity
-
- PHS202001 Solicitation number
- Contract value 100% obligated
- $392,343.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 18 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $392,343 |
About this award
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Reveal Biosciences Inc., a self-certified small disadvantaged business, for SBIR Phase I efforts on the topic of "Artificial Intelligence-Aided Imaging for Cancer Prevention, Diagnosis, and Monitoring." The potential value of the contract is $392,343.00. Reveal Biosciences is a computational pathology company that develops AI-enabled imaging platforms for cancer research and diagnosis. This contract is a Total Small Business set-aside and is part of the NIH's Small Business Innovation Research (SBIR) program, which supports small businesses in creating innovative technologies to address high-priority research and development needs.
Quick answers
Who was awarded contract 75N91020C00051?
75N91020C00051 was awarded to Reveal Biosciences Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2020.
How much is contract 75N91020C00051 worth?
The government has obligated $392,343 on 75N91020C00051.
Was contract 75N91020C00051 competed?
The extent of competition for 75N91020C00051 was full and open competition after exclusion of sources. The government received 18 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award